Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Feb 27, 2026; 18(2): 114378
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114378

Table 2 Comparative therapeutic outcomes, n (%)

CR: Complete remission; PR: Partial remission; PD: Progressive disease; SD: Stable disease; ORR: Objective response rate; DCR: Disease control rate.

Citation: Yu Y, Yuan W, Lei J, Zhao CB, Tao CG, Liu SH, Wang BL. Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. World J Gastrointest Surg 2026; 18(2): 114378
URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114378.htm
DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114378

Yu Y, Yuan W, Lei J, Zhao CB, Tao CG, Liu SH, Wang BL. Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. World J Gastrointest Surg 2026; 18(2): 114378 [PMID: 41809339 DOI: 10.4240/wjgs.v18.i2.114378]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.